Case-Based Roundtable Meetings Spotlight June 2021: Hematologic Malignancies

Roundtable Discussion: Combination Therapies Available for Relapsed Patients With Triple-Refractory Multiple Myeloma

July 08, 2021

Clinical Articles

For patients who relapsed on their prior therapy and have triple-refractory multiple myeloma, selecting the best next-line of therapy is an important decision for their disease outcome. During a Targeted Oncology Case-Based Roundtable event, Peter Forsberg, MD, discussed this topic with a group.

Importance of Achieving MRD Negativity Considered for Transplant-Eligible Multiple Myeloma

June 27, 2021

Clinical Articles

Regarding the case of a 51-year-old man who first presented with pallor and worsening fatigue on exertion and was diagnosed with transplant-eligible multiple myeloma, Rafael Fonseca, MD, discussed available treatment options.